Neurological channelopathies
Open Access
- 1 January 2005
- journal article
- review article
- Published by Oxford University Press (OUP) in Postgraduate Medical Journal
- Vol. 81 (951) , 20-32
- https://doi.org/10.1136/pgmj.2004.022012
Abstract
Ion channels are membrane-bound proteins that perform key functions in virtually all human cells. Such channels are critically important for the normal function of the excitable tissues of the nervous system, such as muscle and brain. Until relatively recently it was considered that dysfunction of ion channels in the nervous system would be incompatible with life. However, an increasing number of human diseases associated with dysfunctional ion channels are now recognised. Such neurological channelopathies are frequently genetically determined but may also arise through autoimmune mechanisms. In this article clinical, genetic, immunological, and electrophysiological aspects of this expanding group of neurological disorders are reviewed. Clinical situations in which a neurological channelopathy should enter into the differential diagnosis are highlighted. Some practical guidance on how to investigate and treat this complex group of disorders is also included.Keywords
This publication has 82 references indexed in Scilit:
- Genetic variation of CACNA1H in idiopathic generalized epilepsyAnnals of Neurology, 2004
- The K–Cl cotransporter KCC3 is mutant in a severe peripheral neuropathy associated with agenesis of the corpus callosumNature Genetics, 2002
- Mutant GABAA receptor γ2-subunit in childhood absence epilepsy and febrile seizuresNature Genetics, 2001
- Multiple interacting gene products may influence susceptibility to malignant hyperthermiaAnnals of Human Genetics, 2000
- Clinical, electrophysiological, and molecular genetic studies in a new family with paramyotonia congenitaJournal of Neurology, Neurosurgery & Psychiatry, 2000
- Randomized trials of dichlorphenamide in the periodic paralysesAnnals of Neurology, 2000
- Salbutamol treatment in a patient with hyperkalaemic periodic paralysis due to a mutation in the skeletal muscle sodium channel gene (SCN4A)Journal of Neurology, Neurosurgery & Psychiatry, 1998
- Autosomal dominant nocturnal frontal lobe epilepsyBrain, 1995
- A calcium channel mutation causing hypokalemic periodic paralysisHuman Molecular Genetics, 1994
- Clinical and electrophysiological reports in a case of early onset myotonia congenita (Thomsen's disease) successfully treated with mexiletineActa Paediatrica, 1992